BioSpace News Archive

Business

BioArctic - Full Year Report January - December 2018

BioArctic’s partner Eisai will initiate BAN2401 confirmatory Phase 3-study in early Alzheimer’s disease. AbbVie in-licensed the Parkinson portfolio

February 14, 2019

·

8 min read

Business

Indivior FY 2018 Financial Results

FY 2018 Adjusted Financial Results In-Line with Guidance. FY 2019 SUBLOCADE™ Guidance Introduced.

February 14, 2019

·

78 min read

Pharm Country

Nikon Announces Z 24-70mm f/2.8 Lens for Full-Frame Mirrorless Cameras; More Info at B&H

Photography News: Joining Nikon’s full-frame mirrorless lens lineup is the pro-oriented NIKKOR Z 24-70mm f/2.8 S Lens

February 14, 2019

·

2 min read

Business

Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe

Arvelle Therapeutics GmbH to provide SK Biopharmaceuticals an upfront payment of $100 million with future milestone potential of up to $430 million

February 14, 2019

·

6 min read

FDA

RDD Pharma Receives Fast Track Designation from FDA for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients

RDD Pharma, Inc. announced that the U.S. Food and Drug Administration granted Fast Track status for RDD-0315 for the treatment of fecal incontinence in spinal cord injury patients.

February 14, 2019

·

2 min read

Business

AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma

Multi-year agreement will provide access to AbCellera’s expertise and state-of-the-art antibody discovery technology for up to ten clinically-relevant disease targets.

February 14, 2019

·

2 min read

Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride

Tradjenta (linagliptin) demonstrated no increased cardiovascular risk compared with glimepiride in adults with type 2 diabetes and cardiovascular risk

February 14, 2019

·

13 min read

Genetown

Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System

Expansion of CorPath GRX into neurovascular intervention could mark first step in revolutionizing stroke treatment

February 14, 2019

·

6 min read

Business

Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

Fourth quarter diluted EPS of $0.92 on a reported basis, down 49.5% from 2017 which included a tax benefit recorded as a result of the Tax Cuts and Jobs Act (TCJA); and $1.36 on an adjusted basis excluding amortization, down 2.9% from 2017

February 14, 2019

·

20 min read

Drug Development

Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Program with Three New Phase 3 Trials

Research Program Expanded Based on Promising Data Shown with KEYTRUDA® (pembrolizumab) in Combination with LYNPARZA® (olaparib), Chemotherapy and Anti-Hormone Agents in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

February 14, 2019

·

43 min read